Ji Hoon Park

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Ulcerative Colitis

Endoscopic Submucosal Dissection

Fluorescence Imaging

Top Venues

APL bioengineering

The American journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Chan Su Park, Hyun Jin Park, Ji Hoon Park, Jin Hee Lee, Hyun Jung Kee, Jung Hoon Park, Jung Hyun Jo, Hee Seung Lee, Cheol-Ryong Ku, Jeong Youp Park, Seungmin Bang, Jung Min Song, Kun Na, Sung Kwon Kang, Hwoon Yong Jung, Moon-Jae Chung
Highly functional duodenal stent with photosensitizers enables photodynamic therapy for metabolic syndrome treatment: Feasibility and safety study in a porcine model. APL bioengineering 8 (3) (2024)
Chan Su Park, Hyun Jin Park, Ji Hoon Park, Jin Hee Lee, Hyun Jung Kee, Jung Hoon Park, Jung Hyun Jo, Hee Seung Lee, Cheol-Ryong Ku, Jeong Youp Park, Seungmin Bang, Jung Min Song, Kun Na, Sung Kwon Kang, Hwoon Yong Jung, Moon-Jae Chung
Highly functional duodenal stent with photosensitizers enables photodynamic therapy for metabolic syndrome treatment: Feasibility and safety study in a porcine model. APL bioengineering 8 (3) (2024)
Galam Leem, Min Je Sung, Ji Hoon Park, So Jeong Kim, Jung Hyun Jo, Hee Seung Lee, Nam Su Ku, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Si Young Song, Moon Jae Chung
Randomized trial of prophylactic antibiotics for endoscopic retrograde cholangiopancreatography in patients with biliary obstruction. The American journal of gastroenterology (2023)
Sung Chan Kwon, Seungmin Bang, Young Nyun Park, Ji Hoon Park, So Jeong Kim, Jung Hyun Jo, Moon-Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Eunhyang Park, Hee Seung Lee
The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer. Gut and liver (2022)
Ji Hoon Park, Jung Hyun Jo, Sung-Ill Jang, Moon-Jae Chung, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Si Young Song, Hee Seung Lee, Jae-Hee Cho
BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients. Cancers 14 (1) (2022)